関: PET, 18F-FDG, FDG PET

WordNet

stroke or caress in an erotic manner, as during lovemaking
a domesticated animal kept for companionship or amusement
a fit of petulance or sulkiness (especially at what is felt to be a slight)
stroke or caress gently; "pet the lamb"
the 16th letter of the Roman alphabet (同)p
the 6th letter of the Roman alphabet (同)f

PrepTutorEJDIC

『愛がん動物』,ペット / 《単数形で》お気に入りの人(物) / (動物などが)愛がん用の,ペットの / (名前などが)愛情を表す / お気に入りの;お得意の / …‘を'愛撫(あいぶ)する,かわいがる
(ささいなことについての)不きげん,すねること
parking
phosphorusの化学記号

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 小腸腫瘍の診断および病期分類 diagnosis and staging of small bowel neoplasms
2. 小児における神経画像検査へのアプローチ approach to neuroimaging in children
3. 骨転移、多発性骨髄腫、およびリンパ腫における完全および切迫病的骨折の評価およびマネージメント evaluation and management of complete and impending pathologic fractures in patients with metastatic bone disease multiple myeloma and lymphoma
4. 副腎偶発腫 the adrenal incidentaloma
5. Management of the neck following definitive radiotherapy with or without chemoradiotherapy in head and neck squamous cell carcinoma

English Journal

FDG-PET Response-adapted Therapy: Is 18F-Fluorodeoxyglucose Positron Emission Tomography a Safe Predictor for a Change of Therapy?

Hutchings M.Author information Department of Haematology, Rigshospitalet, 9 Blegdamsvej, DK-2100 Copenhagen, Denmark. Electronic address: martin.hutchings@gmail.com.AbstractFluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) is the most accurate tool for staging, treatment monitoring, and response evaluation in Hodgkin lymphoma (HL). Early determination of treatment sensitivity by FDG-PET is the best tool to guide individualized, response-adapted treatment. Several ongoing or recently completed trials have investigated the use of FDG-PET/CT for early response-adapted HL therapy. The results are encouraging, but the data are immature, and PET response-adapted HL therapy is discouraged outside the setting of clinical trials. PET/CT looks promising for selection of therapy in relapsed and refractory disease, but the role in this setting is still unclear.
Hematology/oncology clinics of North America.Hematol Oncol Clin North Am.2014 Feb;28(1):87-103. doi: 10.1016/j.hoc.2013.10.008.
Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) is the most accurate tool for staging, treatment monitoring, and response evaluation in Hodgkin lymphoma (HL). Early determination of treatment sensitivity by FDG-PET is the best tool to guide individualized, respon
PMID 24287070

Agrammatic primary progressive aphasia in two dextral patients with right hemispheric involvement.

Jeong EH, Lee YJ, Kwon M, Kim JS, Na DL, Lee JH.Author information a Department of Neurology , Asan Medical Center, University of Ulsan College of Medicine , Seoul , Republic of Korea.AbstractAgrammatic primary progressive aphasia (PPA-G) has been known to be associated with focal brain atrophy involving the left posterior frontal and anterior insular regions. However, aphasia can also rarely result from right hemispheric lesions in right-handed patients, so-called crossed aphasia in dextrals (CAD). We report two right-handed patients with PPA-G whose 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) showed hypometabolism predominantly in the right hemisphere, implicating "crossed PPA-G."
Neurocase.Neurocase.2014 Feb;20(1):46-52. doi: 10.1080/13554794.2012.732084. Epub 2012 Oct 11.
Agrammatic primary progressive aphasia (PPA-G) has been known to be associated with focal brain atrophy involving the left posterior frontal and anterior insular regions. However, aphasia can also rarely result from right hemispheric lesions in right-handed patients, so-called crossed aphasia in dex
PMID 23058062

Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview.

Evangelista L, Cervino AR, Chondrogiannis S, Marzola MC, Maffione AM, Colletti PM, Muzzio PC, Rubello D.Author information aRadiotherapy and Nuclear Medicine Unit bOncological Radiology Unit, Istituto Oncologico Veneto IOV - IRCCS, Padova cDepartment of Imaging, Nuclear Medicine, Radiology Interventional Radiology, Neuroradiology, Medical Physics, Nuclear Medicine & PET/CT Centre, Santa Maria della Misericordia Hospital, Rovigo, Italy dDepartment of Radiology, Los Angeles University, California, USA.AbstractThe outcome of head and neck squamous cell cancer depends primarily on its prompt diagnosis and treatment. Unfortunately, in many cases ominous prognostic factors such as lymph node metastases or osteomandibular extension are present at the time of diagnosis. We review the relative efficacy of contrast-enhanced computed tomography (ceCT), MRI, and F-fluorodeoxyglucose (F-FDG) PET/computed tomography (CT) in the early detection of head and neck squamous cell cancer, as well as its impact on treatment management and outcomes. Medline and Web of Knowledge databases, from 2000 to January 2013, were evaluated. Ninety-seven reports were selected, but only 11 studies comparing PET or PET/CT with CT and 11 comparing PET or PET/CT with MRI were found appropriate for analysis. ceCT and MRI continue to be the reference imaging modalities for the study of primary tumors, especially in the evaluation of the extension of disease and its relationship with nearby anatomical structures. There is increasing evidence that F-FDG PET/ceCT can provide accurate anatomical details similar to ceCT alone, as well as accurate information on osteomandibular tumor invasion similar to MRI. The major advantage of PET/CT over other imaging methods is its ability to detect relatively small lymph node metastases located in difficult-to-interpret positions. PET/CT is also highly sensitive for the detection of distant metastases and in assessing the response to chemotherapy or chemoradiation treatment and in predicting outcome. ceCT and MRI are the gold standards for evaluating primary and osteomandibular tumoral infiltration. F-FDG PET/CT plays a major role in the detection of lymph node and distant metastases, in assessing the response to neoadjuvant/adjuvant chemotherapy or chemoradiation therapy, and in predicting outcome.
Nuclear medicine communications.Nucl Med Commun.2014 Feb;35(2):123-34. doi: 10.1097/MNM.0000000000000022.
The outcome of head and neck squamous cell cancer depends primarily on its prompt diagnosis and treatment. Unfortunately, in many cases ominous prognostic factors such as lymph node metastases or osteomandibular extension are present at the time of diagnosis. We review the relative efficacy of contr
PMID 24220055